Transcript laboratoires genevrier

LABORATOIRES
GENEVRIER
Jeremy Bradshaw
Lucie-Anne Henry
Roberto J. Hinojosa
Presentation of the company
• Biotechnological laboratory founded in1920 in
Neuilly-sur-Seine, France.
• 1987: move to the heart of Sophia Antipolis
research park to be close with Swiss partner
Laboratoires IBSA (Controlling Interest)
• Operating with state of the art Production unit
and Research & Development center
• Major fields of expertise: Dermatology,
Rhumatology, Pneumology, Physical and sport
medicine
•
2006 : MEDEC, Best French laboratory
Presentation of the company
• 235 employees
• Turnover ~ 69 Million € in 2003 *
• 14% to 18% of turnover is dedicated
to R&D
• Customers: (99% of products are prescriptive
drugs)
– Direct: Health Professional
– Indirect: Patients
• Suppliers: Doctors, Professors, Professional
scientists
* http://www.cadremploi.fr/emploi/interview?itwId=14556882
Technology portfolio
• The Laboratoires
Genévrier
Biotechnology Centre
for cell therapy
– EPIBASE autologous skin
care
• Creation of a new drug
every 18 months
• The Modes of Tech.
Access
– In-house R&D
– Non-equity R&D Joint
Venture
From a tiny skin sample (biopsy), EPIBASE®, provides on 85 cm² skin layer available
in 3 weeks and is a simple application treatment that helps start the healing process.
Keratinocytes are specialist cells in the epidermis. Keratinocytes migrate from
the depths of the skin to the surface, filling themselves with a protein: keratin.
This protein gives the epidermis its protective properties against the external
environment.
EPIBASE®: from biopsy to fitting
Contact
• Thibault Machavoine
– Reporting & Purchasing department
– [email protected]
BP 47. 06901 Sophia-Antipolis Cedex
280, rue de Goa. Z.I - Les Trois Moulins
Parc de Sophia-Antipolis 06600 Antibes
Tél. 33 (0) 4 92 91 15 60
Fax 33 (0) 4 92 91 15 30